Keywords
type 1 diabetes mellitus, dyslipidemia, markers, mechanism
Abstract
Diabetes mellitus (DM) makes a significant contribution to global mortality statistics. According to the latest WHO data (2020) DM is the seventh most common cause of mortality. Atherogenic dyslipidemia is one of the main risk factors for cardiovascular disease in patients with type 1 and type 2 diabetes mellitus, in people with abdominal obesity, insulin resistance, or impaired glucose tolerance. In DM type 1 dyslipidemia has a quantitative and qualitative characteristic. This review article demonstrates the role of insulin in lipoprotein metabolism and quantitative lipid profile disorders in DM type 1 and their association with cardiovascular diseases.